Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Prostate Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00949962
What this trial is testing

Post-operative or Early Salvage XRT and ADT for High Risk PCa

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 87
Large-scale testing (Phase 3)WithdrawnNCT03488810
What this trial is testing

Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableLooking for participantsNCT07172685
What this trial is testing

Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC

Who this might be right for
Prostate Cancer
Qilu Hospital of Shandong University 116
Large-scale testing (Phase 3)Study completedNCT01715285
What this trial is testing

Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 1,209
Testing effectiveness (Phase 2)UnknownNCT05285319
What this trial is testing

Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Cairo University 82
Testing effectiveness (Phase 2)Study completedNCT04614363
What this trial is testing

68 Ga-PSMA for High Risk Prostate Cancer

Who this might be right for
Prostate CancerHigh Risk
The Methodist Hospital Research Institute 80
Large-scale testing (Phase 3)Active Not RecruitingNCT02446444
What this trial is testing

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University of Sydney 802
Not applicableUnknownNCT04773821
What this trial is testing

Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 260
Testing effectiveness (Phase 2)Study completedNCT03518606
What this trial is testing

Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumoursBreast CancerHead and Neck Cancer+2 more
UNICANCER 126
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Not applicableNot Yet RecruitingNCT07492381
What this trial is testing

A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
ALPFA Medical 50
Not applicableActive Not RecruitingNCT05361902
What this trial is testing

A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Erasmus Medical Center 35
Early research (Phase 1)WithdrawnNCT00691977
What this trial is testing

Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate

Who this might be right for
Prostate Cancer
Virginia Commonwealth University
Not applicableLooking for participantsNCT07219303
What this trial is testing

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center 80
Large-scale testing (Phase 3)Looking for participantsNCT06952803
What this trial is testing

Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Who this might be right for
Prostate Cancer
AstraZeneca 700
Testing effectiveness (Phase 2)Study completedNCT00551525
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 67
Not applicableLooking for participantsNCT04894188
What this trial is testing

Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03637543
What this trial is testing

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 29
Testing effectiveness (Phase 2)Study completedNCT03113617
What this trial is testing

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma
Andrei Iagaru 44
Early research (Phase 1)Looking for participantsNCT06613100
What this trial is testing

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Amgen 40
Next Page